Literature DB >> 2937991

Fluctuations of plasma lipoprotein-A concentrations during pregnancy and post partum.

R Zechner, G Desoye, M O Schweditsch, K P Pfeiffer, G M Kostner.   

Abstract

The changes in plasma lipoprotein-a Lp-a concentrations during pregnancy were investigated. Out of 42 women with normal pregnancy, 22 reached Lp-a values greater than 10 mg/dL. Plasma levels of Lp-a in addition to total cholesterol, and apolipoprotein B were measured at 4 to 6-week intervals during pregnancy and post partum. The hormones hCG, human placenta lactogen, progesterone, estradiol, and insulin were measured concomitantly. The results can be summarized as follows: Plasma Lp-a concentrations rose steadily during the first trimester of pregnancy and reached a maximum in the middle of the second trimester. Maximal Lp-a values in the 19th week on average were 2.8 times higher as compared to the values of the eight week of pregnancy. Plasma Lp-a fell from the 19th week of pregnancy, reaching a basal value at the time of birth. This value remained virtually unchanged until 6 months post partum. Despite the fact that apolipoprotein-B and total cholesterol rose significantly, exhibiting pronounced maxima during the course of pregnancy, there was no overlap in the shape of their concentration curve with Lp-a. The rise in plasma Lp-a concentration did not correlate with any of the measured hormones at a given time interval. Time shifted analysis of the concentration curve revealed a correlation with hCG, however, with a lag phase of approximately 11 weeks. This study substantiates the independent metabolic control of Lp-a, as compared to plasma apolipoprotein-B and total cholesterol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937991     DOI: 10.1016/0026-0495(86)90150-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

Review 1.  Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins.

Authors:  M Seed
Journal:  Drugs       Date:  1994       Impact factor: 9.546

2.  Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin.

Authors:  E Koukkou; G F Watts; J Mazurkiewicz; C Lowy
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

3.  Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.

Authors:  J C Mazurkiewicz; G F Watts; F G Warburton; B M Slavin; C Lowy; E Koukkou
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

Review 4.  Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease.

Authors:  Aneesha Thobani; Lauren Hassen; Laxmi S Mehta; Anandita Agarwala
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

5.  Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

Authors:  H Dieplinger; C Lackner; F Kronenberg; C Sandholzer; K Lhotta; F Hoppichler; H Graf; P König
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 6.  Lipoprotein(a): new insights into an atherogenic lipoprotein.

Authors:  W Bartens; C Wanner
Journal:  Clin Investig       Date:  1994-08

Review 7.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

Review 8.  Dyslipidemia in women: etiology and management.

Authors:  Binh An P Phan; Peter P Toth
Journal:  Int J Womens Health       Date:  2014-02-07

Review 9.  Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.

Authors:  Motasim M Jawi; Jiri Frohlich; Sammy Y Chan
Journal:  J Lipids       Date:  2020-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.